ATLANTA, GA, November 14, 2002 --- MDdatacor, inc., a medical informatics company that utilizes patent-pending technology to rapidly identify patient populations for clinical trials, approved therapeutics and medical devices, today announced it successfully raised an additional $2.3 million in private equity financing.

The additional capital was secured from MDdatacor's current investors, including DIANON Systems, Inc. (NASDAQ: DIAN), a national provider of cancer and genomic diagnostic services. To date, MDdatacor has raised $6.4 million in aggregate proceeds from the sale of its Common Stock.

"Our information services have been very well received by pharmaceutical and medical device companies. These funds will enable us to successfully execute on a number of recent industry contracts as well as scale our business to meet increased future demand," commented Blake Whitney, MDdatacor chairman and chief executive officer.